In 2016, sales for Zoladex were $69 million in the US and Canada, and $816 million globally. AstraZeneca will continue to market Zoladex outside the US and Canada. The transaction is expected to ...

Myovant will doubtless need the marketing muscle of its partner as it tries to dislodge AbbVie and Neurocrine Biosciences' rival drug Oriahnn (elagolix), which has already been on the US market ...

American companies are investing more in their future and getting a better return on their investments than overseas peers, ...

A $1.8 trillion corner of the sustainable debt market is defying the wider downturn, as investors snap up bonds largely ...

Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights. The Dow Jones concluded trading with a slight increase of 0.08 percent ...

Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights. The Dow Jones is currently trading at 42,576.03, a decline of 0.03 percent ...

As Dan Coatsworth, an investment analyst at AJ Bell, said: "Many people have been worried about elevated valuations among US equities for some time and looking for the catalyst for a market ...

US market is looking to open lower as Dow, S&P 500 and Nasdaq set to give back yesterday's gains. (Reuters ) The US stock market investors are experiencing a roller coaster ride, thanks to an ...

These changes could undermine economic risk growth and increase recession risk, in turn hitting the $60 trillion US stock market. Investors are so rattled that the S&P 500 has lost 4.5% so far ...

With the US market rising more than 50% in 2023 and 2024, it’s been easy to ignore the rest of the world, Mark Lister writes. After two consecutive years of 25% plus returns, the US sharemarket ...

with job gains increasing slightly and the unemployment rate rising to 4.1% amid heightened investor fears over the trajectory of the US labor market and the broader economy. Data from the Bureau ...